ArticleMaterials today. Bio2026
Corrigendum to "Tumor-homing exosomes enable targeted delivery of siRNA and isoimperatorin for overcoming BTK inhibitor resistance in DLBCL" [Mater. Today Bio (35) 102267].
Ruowen Sun et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.